Cargando…

Incidence of tuberculosis in human immunodeficiency virus-infected children in India: Is there a role of isoniazid preventive therapy?

AIM: The aim of this study is to determine the role of isoniazid preventive therapy (IPT) in human immunodeficiency virus (HIV)-infected children in India. MATERIALS AND METHODS: Factors associated with the development of tuberculosis (TB) in 81 HIV-infected children were analyzed. RESULTS: The mean...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shetty, Naman S., Shah, Ira
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532490/ https://www.ncbi.nlm.nih.gov/pubmed/31143856 http://dx.doi.org/10.4103/ijstd.IJSTD_59_18

Ejemplares similares

Isoniazid for preventing tuberculosis in HIV‐infected children
por: Zunza, Moleen, et al.
Publicado: (2017)

Duration of anti-tuberculous therapy in children with persistent tuberculomas
por: Shah, Ira, et al.
Publicado: (2019)

Tracking the rate of initiation and retention on isoniazid preventive therapy in a high human immunodeficiency virus and tuberculosis burden setting of Lesotho
por: Mugomeri, Eltony, et al.
Publicado: (2019)

Isoniazid Preventive Therapy and Risk for Resistant Tuberculosis
por: Balcells, Maria Elvira, et al.
Publicado: (2006)

Prevalence and clinical profile of glycogen storage diseases in children from Western India
por: Shah, Ira, et al.
Publicado: (2020)

Effectiveness of isoniazid preventive therapy on incidence of tuberculosis among HIV-infected adults in programme setting
por: Padmapriyadarsini, C., et al.
Publicado: (2020)

Completion of isoniazid preventive therapy among human immunodeficiency virus positive adults in urban Malawi
por: Thindwa, D., et al.
Publicado: (2018)

Isoniazid Preventive Therapy and Pregnancy Outcomes in Women Living With Human Immunodeficiency Virus in the Tshepiso Cohort
por: Salazar-Austin, Nicole, et al.
Publicado: (2019)

Optimization of dosing regimens of isoniazid and rifampicin in children with tuberculosis in India
por: Aruldhas, Blessed Winston, et al.
Publicado: (2019)

Efficacy of isoniazid prophylactic therapy in prevention of tuberculosis in children: a meta–analysis
por: Ayieko, James, et al.
Publicado: (2014)

Beneficial Effect of Isoniazid Preventive Therapy and Antiretroviral Therapy on the Incidence of Tuberculosis in People Living with HIV in Ethiopia
por: Yirdaw, Kesetebirhan Delele, et al.
Publicado: (2014)

Bone health in HIV-infected children on antiretroviral therapy: An Indian study
por: Bhise, Shruti, et al.
Publicado: (2021)

Isoniazid Preventive Therapy among Children Living with Tuberculosis Patients: Is It Working? A Mixed-Method Study from Bhopal, India
por: Singh, Akash Ranjan, et al.
Publicado: (2017)

Isoniazid preventive therapy: Uptake, incidence of tuberculosis and survival among people living with HIV in Bulawayo, Zimbabwe
por: Nyathi, Saziso, et al.
Publicado: (2019)

Isoniazid Adherence Reduces Mortality and Incident Tuberculosis at 96 Weeks Among Adults Initiating Antiretroviral Therapy With Advanced Human Immunodeficiency Virus in Multiple High-Burden Settings
por: Gupta, Amita, et al.
Publicado: (2022)

A community-based isoniazid preventive therapy for the prevention of childhood tuberculosis in Ethiopia
por: Datiko, D. G., et al.
Publicado: (2017)

High Incidence of Tuberculosis in the Absence of Isoniazid and Cotrimoxazole Preventive Therapy in Children Living with HIV in Northern Ethiopia: A Retrospective Follow-Up Study
por: Alemu, Yihun Mulugeta, et al.
Publicado: (2016)

Risk of Disease After Isoniazid Preventive Therapy for Mycobacterium tuberculosis Exposure in Young HIV-uninfected Children
por: Luabeya, Kany Kany A., et al.
Publicado: (2015)

Active household contact screening for tuberculosis and provision of isoniazid preventive therapy to under-five children in Afghanistan
por: Sayedi, Said Mirza, et al.
Publicado: (2020)

Incidence of Tuberculosis and Associated Mortality in a Cohort of Human Immunodeficiency Virus-Infected Children Initiating Antiretroviral Therapy
por: Salvadori, Nicolas, et al.
Publicado: (2017)

Comparison of tuberculin skin test and QuantiFERON-TB Gold In-Tube test in Bacillus Calmette–Guerin-vaccinated children
por: Shah, Ira, et al.
Publicado: (2020)

643 The effectiveness of Isoniazid Preventive Therapy in reducing incidence of Tuberculosis among HAART receiving HIV-infected patients: A retrospective study
por: Shiferaw, Bethel
Publicado: (2014)

Incidence of tuberculosis among PLHIV on antiretroviral therapy who initiated isoniazid preventive therapy: A multi-center retrospective cohort study
por: Kazibwe, Andrew, et al.
Publicado: (2022)

Effect of Isoniazid Preventive Therapy on the Incidence of Tuberculosis among Seropositive Children Attending HIV/AIDS Care in Two General Hospitals, Northwest Ethiopia, 2021
por: Kebede, Fassikaw, et al.
Publicado: (2021)

Individual and Composite Adverse Pregnancy Outcomes in a Randomized Trial on Isoniazid Preventative Therapy Among Women Living With Human Immunodeficiency Virus
por: Theron, Gerhard, et al.
Publicado: (2020)

Adverse effects of isoniazid preventative therapy for latent tuberculosis infection: a prospective cohort study
por: Denholm, Justin T, et al.
Publicado: (2014)

Pellagra in isoniazid preventive and antiretroviral therapy
por: Kipsang, John Koech, et al.
Publicado: (2019)

Hyperglycaemia induced by isoniazid preventive therapy
por: Ganguly, Roshni Jhan, et al.
Publicado: (2018)

Tuberculosis Contact Screening and Isoniazid Preventive Therapy Among Children Under 5 in the Mbeya and Songwe Regions, Tanzania
por: Mwasubila, Yesaya K, et al.
Publicado: (2018)

Safety and Effectiveness of Isoniazid Preventive Therapy in Pregnant Women Living with Human Immunodeficiency Virus on Antiretroviral Therapy: An Observational Study Using Linked Population Data
por: Kalk, Emma, et al.
Publicado: (2020)

Effect of isoniazid preventive therapy on tuberculosis incidence and associated risk factors among HIV infected adults in Tanzania: a retrospective cohort study
por: Sabasaba, Amon, et al.
Publicado: (2019)

Effect of Isoniazid Prophylaxis Therapy on the Prevention of Tuberculosis Incidence and Associated Factors Among HIV Infected Individuals in Northwest Ethiopia: Retrospective Cohort Study
por: Beshaw, Mulat Addis, et al.
Publicado: (2021)

Factors associated with isoniazid resistant tuberculosis among human immunodeficiency virus positive patients in Swaziland: a case-control study
por: Dlamini, Nonhlanhla Christinah, et al.
Publicado: (2019)

Safety and tolerability of isoniazid preventive therapy for tuberculosis for persons with HIV with and without alcohol use
por: Hahn, Judith A., et al.
Publicado: (2023)

Incidence and Risk Factors of Tuberculosis in Patients with Human Immunodeficiency Virus Infection
por: Hwang, Jeong-Hwan, et al.
Publicado: (2013)

Adherence with isoniazid for prevention of tuberculosis among HIV-infected adults in South Africa
por: Szakacs, Tom A, et al.
Publicado: (2006)

Human immunodeficiency virus polyarthropathy
por: Lakshmanan, Priyanka, et al.
Publicado: (2016)

Effect of isoniazid preventive therapy on tuberculosis or death in persons with HIV: a retrospective cohort study
por: Ayele, Henok Tadesse, et al.
Publicado: (2015)

Isoniazid-Induced Severe Hepatotoxicity: An Infrequent but Preventable Cause of Liver Failure in Children Treated for Latent Tuberculosis Infection
por: Desrochers, Dan, et al.
Publicado: (2011)

Neonatal cholestasis due to primary sclerosing cholangitis
por: Shetty, Naman Sadanand, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_clr060uhka30ecs0vpg1jpgnl8